NKGen Biotech Q3 2023 EPS $(2.48) Down From $(1.10) YoY
Portfolio Pulse from Benzinga Newsdesk
NKGen Biotech reported a Q3 2023 EPS of $(2.48), a significant decrease from the $(1.10) reported in the same quarter of the previous year.
November 14, 2023 | 10:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
NKGen Biotech's Q3 2023 earnings per share (EPS) have significantly declined to $(2.48) from $(1.10) year-over-year.
The substantial drop in EPS year-over-year indicates a worsening financial performance for NKGen Biotech, which is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100